The presentation of a trial-in-progress poster for a Phase 1/2 clinical study is a significant event for a biotech company like Sensei Biotherapeutics. It indicates progress in their research and development efforts. However, without specific results or outcomes from the study, it's difficult to predict the exact impact on the company's stock.